Indeed, the treatment of cells with tunicamycin, an inhibitor of N-linked glycan biosynthesis that activates the ISR and thus ATF4, was sufficient to increase mtDNA levels independently of infection (Fig. S5). This evidence concerns the gene ATF4 and infection.